- Press Release -

Rockville, Md. The global normal balloon catheter market is set to reach around US$ 2 Bn by 2022 on average growth, according to Fact.MR, as cardiovascular disease and the volume of cardiology interventions keep rising. Reimbursement support for patients with vascular disease and higher healthcare spending add further momentum.

Coronary artery procedures dominate use, nylon leads by material, and hospitals account for most consumption. Europe is the largest region, while Asia Pacific excluding Japan grows fastest.

Indications, Materials and Settings

Coronary artery disease is the leading indication, expected to exceed US$ 1 Bn by 2022 and hold nearly three-fourths of revenue. By raw material, nylon holds about half the market, though polyurethane grows at a faster clip. On the end-user side, hospitals dominate, while cardiac catheterization laboratories expand fastest, helped by rising interventional cardiology and growing numbers of patients with end-stage renal disease undergoing renal replacement therapy.

Europe holds the largest revenue share through the forecast period, Asia Pacific excluding Japan grows quickest, and North America records the lowest CAGR.

Interventional Cardiology Drives Demand

The market runs on procedure volume. As interventional cardiology expands and vascular disease becomes more common, demand for normal balloon catheters holds up. Growth is checked mainly by the high cost of angioplasty procedures and the risks tied to catheterization, including infection and artery collapse.

Suppliers and Their Playbook

The field brings together cardiovascular device specialists and large medical technology firms.

• BIOTRONIK SE & Co. KG., Cordis Corporation, Cook Medical INC, Tokai Medical Products Inc., Hexacath, Meril Life Sciences Pvt. Ltd., B. Braun Melsungen AG, MicroPort Scientific Corporation, Terumo Corporation, Medtronic plc, Boston Scientific Corporation, and Abbott Laboratories are among the key players in the report.

Reading the Market for Decisions

For device makers, growth favours reliable nylon and polyurethane devices serving coronary applications. Investors get a specialised market with steady, procedure-led demand. Procurement and hospital teams can plan around coronary use carrying volume, hospitals leading demand, and Europe offering the largest opportunity while Asia Pacific grows fastest through 2022.

About the Report

Fact.MR's study covers the global normal balloon catheter market for the 2017 to 2022 forecast period, with segmentation by raw material, indication, end user and region. It sizes each segment, maps the competitive field, and weighs the clinical forces shaping demand. Further detail is available in the normal balloon catheter market report.

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. The firm is known for its syndicated research, custom research and consulting solutions, helping clients make decisions on demand, competition, investment, procurement and future growth.